Merck & Co Inc (NYSE:MRK) shares, rose in value, with the stock price down by -0.57% to the previous day’s close as strong demand from buyers drove the stock to $83.94.
Actively observing the price movement in the recent trading, the stock is buoying the session at $84.42, falling within a range of $83.68 and $84.76. The value of beta (5-year monthly) is 0.411 whereas the PE ratio is 12.46 over 12-month period. Referring to stock’s 52-week performance, its high was $134.63, and the low was $84.31. On the whole, MRK has fluctuated by -16.14% over the past month.
With the market capitalization of Merck & Co Inc currently standing at about $212.33 billion, investors are eagerly awaiting this quarter’s results, scheduled for in March. The company’s Forward Dividend Ratio is 3.12, with its dividend yield at 3.72%.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 65.37B, with a low estimate of 15.03B and a high estimate of 16.57B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 15.62B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that MRK’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 1.04, with the price of MRK currently trading nearly -9.55% and -13.74% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 22.47, while the 7-day volatility ratio is showing 1.61% which for the 30-day chart, stands at 2.03%. Furthermore, Merck & Co Inc (MRK)’s beta value is 0.36, and its average true range (ATR) is 2.15.
A comparison of Merck & Co Inc (MRK) with its peers suggests the former has fared considerably weaker in the market. MRK showed an intraday change of -0.57% in today’s session so far, and over the past year, it shrunk by -33.08%%.
Data on historical trading for Merck & Co Inc (NYSE:MRK) indicates that the trading volumes over the past 10 days have averaged 20.99 and over the past 3 months, they’ve averaged 13.42 million. According to company’s latest data on outstanding shares, there are 2.53 billion shares outstanding.
Nearly 0.11% of Merck & Co Inc’s shares belong to company insiders and institutional investors own 79.86% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 34.12 million shares as on 2025-01-15, resulting in a short ratio of 3.46. According to the data, the short interest in Merck & Co Inc (MRK) stood at 135.00 of shares outstanding as of 2025-01-15; the number of short shares registered in 2024-12-13 reached 32.03 million. The stock has fallen by -15.62% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MRK stock heading into the next quarter.
